Figure 2.
Microdystrophins in clinical trial. (A) Full-length dystrophin versus (B) the delivery vectors, promoters, microdystrophins and doses being used in current clinical trials by Pfizer, Sarepta Therapeutics and Solid Biosciences.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.